Radiation Therapy Market:
WiseGuyReports.com adds “Radiation Therapy Global Market – Forecast To 2024” reports to its database.
Executive Summary
Radiation therapy refers to the popular form of cancer treatment. Radiation therapy can completely cure cancer or just give some amount of relief to the sufferings of the patients. It helps in killing the cancerous cells. But its use does have side effects by causing damage to the healthy cells as well as the surrounding organs. The radiation exposure also has the potential to cause secondary cancer.
Radiation therapy is broadly classified into three types, internal radiation therapy, external-beam radiation therapy, and systemic radiation therapy. The internal radiation therapy is done by placing radioactive material inside the patient’s body close to the cancer cells. The external radiation therapy is delivered outside the patient’s body with the help of a machine. In the case of systemic radiation therapy, radioactive substances like radioactive iodine are made to pass through the blood of the cancer patient to kill the cancer cells.
Radiation therapy can be used alone to treat the patients, or it can be used along with chemotherapy, surgery or even at times both. The advancements in technology have helped in developing radiation therapy with lesser side effects — careful planning and treatment help in reducing the risks of complications.
Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/2596180-radiation-therapy-global-market-forecast-to-2024
Market Segmentation
The global radiation therapy market is segmented based on application, product, technology, end-users, and region.
Depending on the application, the global market encompasses prostate cancer, gynaecological cancer, brain cancer, lung cancer, breast cancer, head and neck cancer, gastrointestinal cancer, and other cancers.
Based on the product, the radiation therapy market is divided into external radiation therapy, internal radiation therapy, and systemic radiation therapy. The external therapy is further subdivided into linear accelerators and proton therapy systems. The internal radiation therapy includes seeds, applicators, and after loaders, electronic brachytherapy and accessories. The systemic radiation therapy includes alpha emitters and beta emitters.
Based on technology, the global market is segmented into external radiation therapy and internal radiation therapy. The external radiation therapy is further segmented as Stereotactic Radio Surgery (SRS), Volumetric Modulated Arc Therapy (VMAT), Stereotactic Body Radiation Therapy (SBRT), Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), and Intensity-Modulated Proton Therapy (IMPT). IMRT is expected to occupy the largest market share during the forecast period. The internal radiation therapy includes low dose rate brachytherapy, high dose rate brachytherapy, and others.
Regional Segmentation
The regions included in the global radiotherapy market are North America, Asia Pacific, Europe, and the rest of the world. North America is the market leader in the global scenario owing to the increase of cancer prevalence, easy accessibility, favourable government initiatives, and the adoption of advanced technologies.
The key players of the global radiation therapy market are Elekta, Ion Beam Applications SA, Varian Medical Systems Inc., Hitachi Ltd., Accuray Incorporated, Provision Healthcare, Panacea Medical Technologies Pvt. Ltd., and many others.
Top Industry News
In August 2019, a new model called Genomically Adjusted Radiation Dose (GARD) has been developed to optimize and deliver personalized radiation therapy to cancer patients. The personalized approach aims at meeting the varying requirements of the individual patients.
Continuous…
For further information on this report, visit – https://www.wiseguyreports.com/reports/2596180-radiation-therapy-global-market-forecast-to-2024
Contact US:
sales@wiseguyreports.com
Ph: +1-646-845-9349 (US); +44 208 133 9349 (UK)
Your information will never be shared with any third party.